|
Volumn 12, Issue 6, 1997, Pages 527-546
|
Pharmacology of methylphenidate, amphetamine enantiomers and pemoline in attention-deficit hyperactivity disorder
|
Author keywords
Adderall ; Attention deficit hyperactivity disorder; Dextroamphetamine; Dopamine; Enantiomers; Levoamphetamine; Methylphenidate; Pemoline; Pharmacodynamics; Pharmacokinetics
|
Indexed keywords
AMPHETAMINE;
DESIPRAMINE;
DEXAMPHETAMINE;
FLUOXETINE;
GUANETHIDINE;
IMIPRAMINE;
METHYLPHENIDATE;
PEMOLINE MAGNESIUM;
PHENYLBUTAZONE;
PSYCHOSTIMULANT AGENT;
UNCLASSIFIED DRUG;
ABDOMINAL PAIN;
ADULT;
ANOREXIA;
ATTENTION DEFICIT DISORDER;
CARCINOGENICITY;
CHILD;
DRUG BIOAVAILABILITY;
DRUG CONFORMATION;
DRUG MECHANISM;
ENANTIOMER;
GROWTH INHIBITION;
HEADACHE;
HUMAN;
INSOMNIA;
INTRACEREBROVENTRICULAR DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
IRRITABILITY;
LIVER TOXICITY;
NERVOUSNESS;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
REVIEW;
TACHYCARDIA;
TIC;
VERTIGO;
WEIGHT REDUCTION;
|
EID: 0031460272
PISSN: 08856222
EISSN: None
Source Type: Journal
DOI: 10.1002/(SICI)1099-1077(199711/12)12:6<527::AID-HUP932>3.0.CO;2-U Document Type: Review |
Times cited : (121)
|
References (174)
|